Table of Content



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Overview
N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Companies Involved in Therapeutics Development
Bristol-Myers Squibb Co
CohBar Inc
Limulus Therapeutics Pty Ltd
NovaCell Technology Inc
ResoTher Pharma ApS
Trio Medicines Ltd
N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Drug Profiles
Humanin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NCP-112 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NCP-70X - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RTP-025 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RTP-026 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Agonize FPR-2 for Heart Failure and Inflammation - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Agonize FPR1 and FPR2 for Ischemia Reperfusion Injury - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TR-8 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Dormant Products
N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures



Number of Products under Development by Stage of Development, H2 2019
Number of Products under Development by Therapy Areas, H2 2019
Number of Products under Development by Top 10 Indications, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019


List of Tables



Number of Products under Development by Stage of Development, H2 2019
Number of Products under Development by Therapy Areas, H2 2019
Number of Products under Development by Indication, H2 2019
Number of Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Pipeline by Bristol-Myers Squibb Co, H2 2019
Pipeline by CohBar Inc, H2 2019
Pipeline by Limulus Therapeutics Pty Ltd, H2 2019
Pipeline by NovaCell Technology Inc, H2 2019
Pipeline by ResoTher Pharma ApS, H2 2019
Pipeline by Trio Medicines Ltd, H2 2019
Dormant Projects, H2 2019
Discontinued Products, H2 2019